Whatman/Schleicher & Schuell Partners With IIM For More Rapid And Accurate Diagnosis Of Autoimmune Diseases

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Aug. 8, 2005--Whatman/Schleicher & Schuell, a global leader in separations technology, today announced a partnership with Privates Institut fur Immunologie und Molekulargenetik GmbH (IIM), a premier German laboratory that specializes in autoimmune and other clinical diagnostic assays, to develop, manufacture and distribute a protein biochip for autoimmune disease diagnosis.

MORE ON THIS TOPIC